CASI Pharmaceuticals
CASI
#9476
Rank
NZ$78.39 M
Marketcap
$5.07
Share price
-5.30%
Change (1 day)
-53.39%
Change (1 year)

Earnings for CASI Pharmaceuticals (CASI)

Earnings in 2024 (TTM): -NZ$48.31 Million

According to CASI Pharmaceuticals's latest financial reports the company's current earnings are NZ$22.05 Million. In 2023 the company made an earning of -NZ$46.76 Million, an increase over its 2022 earnings that were of -NZ$66.36 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CASI Pharmaceuticals from 1996 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$48.31 Million3.33%
2023 -NZ$46.76 Million-29.55%
2022 -NZ$66.36 Million4.43%
2021 -NZ$63.55 Million-24.56%
2020 -NZ$84.23 Million4.74%
2019 -NZ$80.42 Million65.13%
2018 -NZ$48.71 Million155.07%
2017 -NZ$19.1 Million13.93%
2016 -NZ$16.76 Million31.18%
2015 -NZ$12.78 Million-72.5%
2014 -NZ$46.46 Million356.62%
2013 -NZ$10.18 Million-60.55%
2012 -NZ$25.79 Million218.41%
2011 -NZ$8.1 Million0.74%
2010 -NZ$8.04 Million-32.54%
2009 -NZ$11.92 Million-66.98%
2008 -NZ$36.09 Million-14.22%
2007 -NZ$42.07 Million7.04%
2006 -NZ$39.31 Million27.95%
2005 -NZ$30.72 Million4.51%
2004 -NZ$29.4 Million-15.84%
2003 -NZ$34.93 Million-55.29%
2002 -NZ$78.12 Million-34.05%
2001 -NZ$0.12 Billion31.73%
2000 -NZ$89.92 Million31.56%
1999 -NZ$68.35 Million145.56%
1998 -NZ$27.84 Million76.4%
1997 -NZ$15.78 Million36.92%
1996 -NZ$11.53 Million